Islamabad : Spokesperson Ministry of Health said that Federal Health Minister Syed Mustafa Kamal visited the Drug Regulatory Authority of Pakistan (DRAP). The Health Minister held a meeting with Senior officials of DRAP including newly appointed Chief Executive Officer, Dr. Obaidullah. CEO DRAP briefs the Federal Minister on the institution’s functions, performance, and challenges.
While addressing to the DRAP officers, Health Minister Syed Mustafa Kamal said that “Our decisions directly impact human lives and the outcomes of our decisions and actions should benefit the common man.” In this respect, the Minister directed that, “the elimination of counterfeit and substandard medicines is imperative.”
“We must protect human lives from potential threats at all costs,” says Syed Mustafa Kamal. He told that “a coordinated strategy will be developed in collaboration with provincial governments to eliminate counterfeit medicines.” “Pharmaceutical industries and local manufacturing should be facilitated and DRAP’s policies should be conducive to investment so that foreign manufacturing companies prioritize investing in Pakistan,” says Syed Mustafa Kamal.
The Federal Health Minister emphasized “to increase medicine exports by adopting international standards. He added that “the journey to elevate DRAP to WHO Level 4 should be accelerated.” During the meeting
Minister further said that a National Medicine Policy will be formulated in consultation with all stakeholders.
